http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104822679-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104822679-B |
| titleOfInvention | Imidazopyridine derivatives |
| abstract | The present invention relates to the compound of logical formula (I), wherein Ar is phenyl or pyridine radicals；X 1 It is N or CH, X 2 Being N or CH, precondition is X 1 Or X 2 Middle only one be N and another be CH；R 1 It is hydrogen, halogen, low alkyl group, lower alkoxy, the low alkyl group being optionally substituted by halogen, cyano group or S (O) 2 ‑ Low alkyl group；R 2 It is hydrogen, halogen, low alkyl group, lower alkoxy, the low alkyl group being optionally substituted by halogen or cyano group；N is 1 or 2；Or relate to its medicinal acid addition salt, racemic mixture or its corresponding enantiomer and/or optical isomer.Described compound may be used for treating schizophrenia, obsessive-compulsive personality disorder, major depressive disorder, bipolar disorder, anxiety neurosis, usual aging, epilepsy, retinal degeneration, traumatic brain injury, spinal cord injury, post-traumatic stress disorder, panic disorder, parkinson disease, dull-witted, Alzheimer, mild cognitive impairment, the cognitive dysfunction that chemotherapy causes, mongolism, autism spectrum disorder, hearing loss, tinnitus, spinocebellar ataxia, amyotrophic lateral sclerosis, multiple sclerosis, Huntington Chorea, apoplexy, radiotherapy, chronic stress, neuroactive drug such as ethanol, opiate, methamphetamine, phencyclidine and the abuse of cocaine. |
| priorityDate | 2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.